Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOtolaryngology Physician in Portland, OR
NPI: 1194984260Primary Practice Location
OHSU HOSPITAL AND CLINICS
700 Sw Campus Dr, Portland, OR
Primary Employer
VA Portland Health Care System
va.gov
HQ Phone
Get M.D. Daniel's Phone Numberphone_androidMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOR State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 2 | 31575Diagnostic examination of voice box using flexible endoscope | 16 | 18 |
Authors: Peter Andersen, Scott Troob, Daniel Brickman, Neil Gross
Journal: Oral Oncol
Publication Date: 2017-05-09
Risk of Suicidal Self-directed Violence Among US Veteran Survivors of Head and Neck Cancer.
Authors: Christopher Slatore
Journal: JAMA Otolaryngol Head Neck Surg
Authors: Ouyang, Xiaoming, Barling, Ashley, Lesch, Aletha, Tyner, Jeffrey W, Choonoo, Gabrielle, Zheng, Christina, Jeng, Sophia, West, Toni M, Clayburgh, Daniel, Courtneidge, Sara A, McWeeney, Shannon K, Kulesz-Martin, Molly
Journal: Cancer Biol Ther
Publication Date: 2018-08-17
Lead Sponsor: Galera Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Low Dose GC4419: 30mg/day, DRUG: High Dose GC4419: 90mg/day
Lead Sponsor: OHSU Knight Cancer Institute
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Best Practice, DIETARY_SUPPLEMENT: Nutritional Intervention
Lead Sponsor: Galera Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: GC4419 90mg
